These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 33117346

  • 1. A Polysaccharide Purified From Ganoderma lucidum Acts as a Potent Mucosal Adjuvant That Promotes Protective Immunity Against the Lethal Challenge With Enterovirus A71.
    Lin YL, Shih C, Cheng PY, Chin CL, Liou AT, Lee PY, Chiang BL.
    Front Immunol; 2020; 11():561758. PubMed ID: 33117346
    [Abstract] [Full Text] [Related]

  • 2. A novel mucosal bivalent vaccine of EV-A71/EV-D68 adjuvanted with polysaccharides from Ganoderma lucidum protects mice against EV-A71 and EV-D68 lethal challenge.
    Lin YL, Cheng PY, Chin CL, Chuang KT, Lin JY, Chang N, Pan CK, Lin CS, Pan SC, Chiang BL.
    J Biomed Sci; 2023 Dec 18; 30(1):96. PubMed ID: 38110940
    [Abstract] [Full Text] [Related]

  • 3. A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge.
    Lin YL, Chow YH, Huang LM, Hsieh SM, Cheng PY, Hu KC, Chiang BL.
    Sci Rep; 2018 Jul 16; 8(1):10713. PubMed ID: 30013088
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine.
    Lin YL, Cheng PY, Chin CL, Huang LM, Lin SY, Chiang BL.
    Vaccine; 2018 Jul 05; 36(29):4331-4338. PubMed ID: 29891349
    [Abstract] [Full Text] [Related]

  • 5. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine.
    Zhang C, Wang Y, Ma S, Li L, Chen L, Yan H, Peng T.
    Viral Immunol; 2016 Jun 05; 29(5):288-95. PubMed ID: 27259043
    [Abstract] [Full Text] [Related]

  • 6. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71.
    Hsieh W-S, Chao C-H, Shen C-Y, Cheng D, Huang S-W, Wang Y-F, Chen C-C, Chen S-H, Hsu L-J, Wang J-R.
    J Virol; 2024 Jan 23; 98(1):e0155823. PubMed ID: 38174926
    [Abstract] [Full Text] [Related]

  • 7. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
    Tsai YH, Huang SW, Hsieh WS, Cheng CK, Chang CF, Wang YF, Wang JR.
    J Virol; 2019 Jul 01; 93(13):. PubMed ID: 30996087
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity and performance of an enterovirus 71 virus-like-particle vaccine in nonhuman primates.
    Lim PY, Hickey AC, Jamiluddin MF, Hamid S, Kramer J, Santos R, Bossart KN, Cardosa MJ.
    Vaccine; 2015 Nov 04; 33(44):6017-24. PubMed ID: 26271825
    [Abstract] [Full Text] [Related]

  • 9. Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge.
    Zhang F, Hao C, Zhang S, Li A, Zhang Q, Wu W, Liu L, Li C, Liang M, Li X, Li D.
    Virol J; 2014 May 06; 11():80. PubMed ID: 24885121
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immune responses against enterovirus A71 infection: Implications for vaccine success.
    Aw-Yong KL, NikNadia NMN, Tan CW, Sam IC, Chan YF.
    Rev Med Virol; 2019 Sep 06; 29(5):e2073. PubMed ID: 31369184
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
    Xu Y, Ma S, Zhu L, Huang Z, Chen L, Xu Y, Yin H, Peng T, Wang Y.
    Antiviral Res; 2017 Jan 06; 137():67-75. PubMed ID: 27864074
    [Abstract] [Full Text] [Related]

  • 15. Emergence of genotype C1 Enterovirus A71 and its link with antigenic variation of virus in Taiwan.
    Huang KA, Huang PN, Huang YC, Yang SL, Tsao KC, Chiu CH, Shih SR, Lin TY.
    PLoS Pathog; 2020 Sep 06; 16(9):e1008857. PubMed ID: 32936838
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.
    Chang J, Li J, Liu X, Liu G, Yang J, Wei W, Zhang W, Yu XF.
    BMC Microbiol; 2015 Jul 15; 15():139. PubMed ID: 26169371
    [Abstract] [Full Text] [Related]

  • 20. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
    Khalil SM, Tonkin DR, Snead AT, Parks GD, Johnston RE, White LJ.
    J Virol; 2014 Aug 15; 88(16):9182-96. PubMed ID: 24899195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.